AbbVie (ABBV)
(Delayed Data from NYSE)
$197.55 USD
+1.18 (0.60%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $197.40 -0.15 (-0.08%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth B Momentum D VGM
Brokerage Reports
0 items in cart
AbbVie Inc. [ABBV]
Reports for Purchase
Showing records 1 - 20 ( 385 total )
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for ABBV 21124
Provider: Stock Traders Daily
Analyst: Research Department
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for ABBV 2124
Provider: Stock Traders Daily
Analyst: Research Department
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for ABBV 12124
Provider: Stock Traders Daily
Analyst: Research Department